IW Campbell - International Journal of Clinical Practice, 2005 - medscape.com Therapy for type 2 diabetes mellitus should aim to control not only fasting, but also postprandial
glucose levels. Nateglinide, a d-phenylalanine derivative, restores postprandial early phase
insulin secretion in a transient and glucose-sensitive manner without affecting basal ... Cited by 15 - Related articles - BL Direct - All 6 versions
JF Blickle - Diabetes and Metabolism, 2006 - Elsevier Glinides represent a chemically heterogeneous new class of insulinsecreting agents characterized
by a rapid onset and short duration of action. They act by closure of the ATP-dependant K
channel. Repaglinide, the only glinide available in France, has an equivalent HbA 1c ... Cited by 16 - Related articles - BL Direct - All 3 versions
KM Utzschneider, RL Prigeon, J Tong, F Gerchman, DB … - Diabetologia, 2007 - Springer Page 1. ARTICLE Within-subject variability of measures of beta cell function derived from a 2
h OGTT: implications for research studies KM Utzschneider & RL Prigeon & J. Tong & F. Gerchman
& DB Carr & S. Zraika & J. Udayasankar & B. Montgomery & A. Mari & SE Kahn ... Cited by 13 - Related articles - BL Direct - All 2 versions
J Li, H Tian, Q Li, N Wang, T Wu, Y Liu, Z Ni, … - Diabetes Obes …, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 8 - Related articles - All 5 versions
- ►qub.ac.uk [PDF] NA Duffy, BD Green, N Irwin, VA Gault, AM McKillop … - European journal of …, 2007 - Elsevier Dipeptidyl peptidase IV (DPP IV) is the primary inactivator of glucoregulatory incretin
hormones. This has lead to development of DPP IV inhibitors as a new class of agents for the
treatment of type 2 diabetes. Recent reports indicate that other antidiabetic drugs, such as ... Cited by 6 - Related articles - All 6 versions
A Mari - Immunology, Endocrine &# 38; Metabolic Agents- …, 2006 - ingentaconnect.com Abstract: Assessment of insulin sensitivity and β-cell function is required in many studies, as
these characteristics are of fundamental importance in glucose intolerance and diabetes, and
insulin sensitivity is also a potential underlying cause of other pathologies. Clinical ... Cited by 4 - Related articles - BL Direct
J Tibaldi - Expert Review of Endocrinology and Metabolism, 2008 - ingentaconnect.com Type 2 diabetes mellitus (T2DM) is a complex disease characterized by insulin resistance and
a progressive decline in β-cell function and mass. Current evidence suggests that β-cell dysfunction
is present early in the course of the disease and that this dysfunction, rather than insulin ... Cited by 3 - Related articles - All 8 versions
S Ristic, C Collober-Maugeais, F Cressier, P … - Diabetes Obes …, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 3 - Related articles - All 3 versions
G Pacini, A Mari - Clinical Diabetes Research: Methods and …, 2007 - books.google.com 3 Assessment of Insulin Sensitivity from Steady-State and Dynamic Tests Giovanni Pacini and
Andrea Mari Introduction Berson & Yalow (1970) defined insulin resistance as'a state in which
greater-than-normal amounts of insulin are required to elicit a quantitatively normal ... Cited by 1 - Related articles - All 2 versions
